After rejecting imports of Bharat Biotech’s COVID-19 vaccine Covaxin towards the end of March, the Brazilian regulator National Health Surveillance Agency of Brazil (Anvisa) has now green-lighted the move for the vaccine’s distribution and use under controlled conditions.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?